These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3540496)

  • 21. Primary and secondary dapsone resistance of M. leprae in Martinique, Guadeloupe, New Caledonia, Tahiti, Senegal, and Paris between 1980 and 1985.
    Guelpa-Lauras CC; Cartel JL; Constant-Desportes M; Millan J; Bobin P; Guidi C; Brucker G; Flageul B; Guillaume JC; Pichet C
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):672-9. PubMed ID: 3323369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 23. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary dapsone-resistant leprosy in Shanghai Municipality.
    Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
    Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
    [No Abstract]   [Full Text] [Related]  

  • 25. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clofazimine-resistant M. leprae.
    Levy L
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):137-40. PubMed ID: 3519801
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulphone resistance and its implications.
    Hogerzeil LM
    Lepr Rev; 1977 Jun; 48(2):123-5. PubMed ID: 330997
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid test for drug resistance in leprosy.
    Ambrose EJ; Khanolkar SR; Antia NH; Chulawalla RG; Koticha KK
    Lancet; 1977 Nov; 2(8046):1036. PubMed ID: 72940
    [No Abstract]   [Full Text] [Related]  

  • 29. [Observation of antileprotic drug resistance].
    Ishihara S; Hagiwara S; Fukuda T
    Nihon Rai Gakkai Zasshi; 1984; 53(4):200-4. PubMed ID: 6399285
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
    Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
    Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: Sulphone resistance in leprosy.
    Browne SG
    Lancet; 1975 Jul; 2(7926):177. PubMed ID: 49763
    [No Abstract]   [Full Text] [Related]  

  • 32. Dapsone-resistant leprosy in Ethiopia.
    Pearson JM; Haile GS; Barnetson RS; Rees RJ
    Lepr Rev; 1979 Sep; 50(3):183-99. PubMed ID: 392212
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
    Sreevatsa ; Ramu G; Desikan KV
    Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India).
    Bhatia VN; Balakrishnan S; Seshadri PS; Neelan PN; Roy RG
    Indian J Lepr; 1984; 56(3):587-94. PubMed ID: 6396340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
    Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851
    [No Abstract]   [Full Text] [Related]  

  • 36. Survey for secondary dapsone and rifampicin resistance in Cuba.
    González AB; Maestre JL; Hernández O; Columbié Y; Atrio N; Martin M; Fernández AM; Rodríguez J
    Lepr Rev; 1993 Jun; 64(2):128-35. PubMed ID: 8341115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary dapsone resistance as assessed by uptake of labelled thymidine by the macrophage resident Mycobacterium leprae.
    Thakur M; Vaishnavi C; Ganguly NK; Kaur S; Kumar B
    Indian J Lepr; 1989 Oct; 61(4):437-41. PubMed ID: 2695575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 40. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
    Dhople AM
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.